Life-threatening conditions in psychiatry – neuroleptic malignant syndrome (NMS)

Journal Title: Annals of Agricultural and Environmental Medicine - Year 2015, Vol 9, Issue 1

Abstract

The introduction of neuroleptics in the 1950’s was a turning point in psychiatric treatment. The new drugs brought hope to millions of patients and their doctors. However, there were also some side-effects, one of which is Neuroleptic malignant syndrome (NMS), a rare complication of antipsychotic treatment and untreated it may lead to mortality as high as 20%. The incidence of NMS, estimated to be 0.01–0.02%, has decreased significantly probably due to higher awareness of the diseases and shift to atypical antipsychotics. The aim of this study was to present the signs and symptoms of this rare condition and describe management possibilities since this condition is observed not only in psychiatric departments but also in emergency rooms. NMS is thought to be related to change caused by neuroleptics within the central nervous system due to dopamine D2 receptor antagonism, especially nigrostriatal pathways and the hypothalamus. There are three symptoms which are considered as major and indicate a high probability of NMS: muscle rigidity, hyperthermia (core body temperature above 38.5 °C), and elevated creatine phosphokinase concentration (above 1000 U/l). NMS is a diagnosis of exclusion and clinicians must be vigilant in detecting early signs of NMS. The basic management in NMS is antipsychotic discontinuation and proper supportive care of the patient (vital signs monitoring, hydration, correction of electrolyte and acid-base disturbances). In more severe cases, the introduction of bromocriptine or dantrolene, as well as benzodiazepines, may indicated. Further usage of neuroleptic in patients with a history of NMS should be with care, and low doses of low-potency neuroleptics or atypical neuroleptics seem to be the best treatment choice.

Authors and Affiliations

Tomasz Kucmin, Adriana Kucmin, Małgorzata Płowaś-Goral, Mariusz Jojczuk

Keywords

Related Articles

Two generation reproductive and developmental toxicity following subchronic exposure of pubescent male mice to di(2-ethylhexyl)phthalate

Di-(2-ethylhexyl)phthalate (DEHP) is widely present in the human environment.The study aimed at the investigation of potential genotoxic effects induced by subchronic exposure to DEHP in germ cells of male mice in the fi...

Responses of growth of lady’s fingers ([i]Abelmoschus esculentus [/i]L.) to different treatments methods of dairy wastewater

Introduction and objective. Water is one of the most important precious resources found on the earth, and are most often affected by anthropogenic activities and by industry. Pollution caused by human beings and industri...

CT and MRI examination in diagnosis of cerebral venous and sinus thrombosis

Cerebral venous and sinus thrombosis (CVST) is a central nervous system pathology difficult to diagnose due to vague and uncertain clinical symptoms. Nowadays, broad application of neuroimaging has completely modified ou...

Level of magnesium in patients with depression treated with lithium – pilotage research

Introduction. Depression is a major public health problem. Magnesium (Mg[sup]2+[/sup]) is involved in many metabolic processes as an activator of over 300 different enzymes. For the last 60 years lithium (Li[sup]+[/sup])...

Anti-schizophrenic activities of histamine H[sub]3[/sub] receptor antagonists in rats treated with MK-801

Animal models based on N-methyl-d-aspartate (NMDA) receptor blockade have been widely reported. Ketamine and MK-801, the two noncompetitive antagonists of NMDA receptors, produce behaviors related to schizophrenia and ex...

Download PDF file
  • EP ID EP58843
  • DOI -
  • Views 127
  • Downloads 0

How To Cite

Tomasz Kucmin, Adriana Kucmin, Małgorzata Płowaś-Goral, Mariusz Jojczuk (2015). Life-threatening conditions in psychiatry – neuroleptic malignant syndrome (NMS). Annals of Agricultural and Environmental Medicine, 9(1), 74-78. https://europub.co.uk/articles/-A-58843